However, there is still a lack of knowledge on the levels of the key cholinergic enzymes ChAT and AChE in CSF and plasma in untreated patients with AD and in individuals with mild cognitive impairment (MCI) or subjective cognitive impairment (SCI). This evidence concerns the gene ACHE and Alzheimer disease.